Process development for cell culture, upstream and downstream process in production of HIV-1 biomolecules
Ended Awarded Last action
- Contract number
- 75N93019F00269
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,707,175
Award facts
- Opportunity
-
- NIHAI2014013 Solicitation number
- Contract value 100% obligated
- $1,707,175.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- New York, NY 10004, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$19,653 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,726,828 |
About this award
This federal contract award, valued at $1,707,175.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract supports process development for cell culture, upstream and downstream processes in the production of HIV-1 biomolecules, as part of NIAID's broader program for process and analytical support in the development of HIV vaccines. The contract is a Delivery Order, with a Cost Plus Fixed Fee pricing type, and does not have a set-aside designation. IAVI has served as the prime contractor, partnering with the Belgium-based biotechnology company Univercells SA as a major subcontractor to contribute its expertise in biomanufacturing solutions and technologies. This award is part of IAVI's broader work with federal agencies like NIH and BARDA to advance promising vaccine candidates through preclinical and clinical testing across various infectious diseases.
Quick answers
Who was awarded contract 75N93019F00269?
75N93019F00269 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 15, 2019.
How much is contract 75N93019F00269 worth?
The government has obligated $1,707,175 on 75N93019F00269.
Is contract 75N93019F00269 an order under another contract?
Yes. 75N93019F00269 is a delivery order under HHSN272201600011I, an indefinite delivery contract.
Was contract 75N93019F00269 competed?
The extent of competition for 75N93019F00269 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award